Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group Study

As controversy exists regarding the prognostic significance of genomic rearrangements of CRLF2 in pediatric B-precursor acute lymphoblastic leukemia (ALL) classified as standard/intermediate-risk (SR) or high-risk (HR), we assessed the prognostic significance of CRLF2 mRNA expression, CRLF2 genomic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Chen, I-Ming, Harvey, Richard C., Mullighan, Charles G., Gastier-Foster, Julie, Wharton, Walker, Kang, Huining, Borowitz, Michael J., Camitta, Bruce M., Carroll, Andrew J., Devidas, Meenakshi, Pullen, D. Jeanette, Payne-Turner, Debbie, Tasian, Sarah K., Reshmi, Shalini, Cottrell, Catherine E., Reaman, Gregory H., Bowman, W. Paul, Carroll, William L., Loh, Mignon L., Winick, Naomi J., Hunger, Stephen P., Willman, Cheryl L.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Hematology 2012
Schlagworte:
Clinical Trials and Observations
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3325039/
https://ncbi.nlm.nih.gov/pubmed/22368272
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-11-394221
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge